Physician profile
Ankur Dharia
NPI 1134217334
$3,533.76
in general payments reported to CMS, 2019-2025
9 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.00 · 2023: $1,747 · 2024: $1,284 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,564 · Consulting Fee: $1,000 · Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,564.05 |
| Consulting Fee | $1,000.00 |
| Food and Beverage | $871.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,631.17 | 2023-2024 | |
| Stryker Corporation | $1,098.00 | 2019-2024 | |
| Organogenesis INC. | $352.54 | 2023-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Urgo Medical North America, LLC | $234.92 | 2024-2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Biotronik Nro, INC. | $125.67 | 2025 | Prospera |
| Smith+Nephew, INC. | $26.56 | 2025 | Grafix Pl, Stravix Pl |
| Avita Medical Americas, LLC | $26.55 | 2024 | |
| Kerecis Limited | $19.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $18.98 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Dharia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.